Search company, investor...

Trizell

trizell.com

About Trizell

Trizell is a biotechnology company.

Headquarters Location

Sanderum House Oakley Road

Chinnor, England,

United Kingdom

Missing: Trizell's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Trizell's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Trizell Patents

Trizell has filed 1 patent.

The 3 most popular patent topics include:

  • Biotechnology
  • Molecular biology
  • Virology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/17/2020

9/20/2022

Molecular biology, Virology, Biotechnology, Gene delivery, Applied genetics

Grant

Application Date

7/17/2020

Grant Date

9/20/2022

Title

Related Topics

Molecular biology, Virology, Biotechnology, Gene delivery, Applied genetics

Status

Grant

Latest Trizell News

VIDEO: Integrating sequential immunotherapy to lung cancer treatment plans

Jun 24, 2022

Healio Interviews Disclosures: Marmarelis reports holding stock and other ownership interests in Bluebird Bio, Gilead Sciences, Johnson & Johnson, Merck, Pfizer and Portola Pharmaceuticals; receiving honoraria from AstraZeneca, Blueprint Medicines, Health Advances, Janssen Oncology, Novocure, Takeda and Targeted Oncology; serving in a consulting or advisory role for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb/Celgene and Ikena Oncology; receiving research funding to Marmarelis’s institution from AstraZeneca, Lilly and Trizell; receiving travel, accommodations and expenses from Boehringer Ingelheim and Novocure; and having another relationship with Novartis. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio In this video, Melina Marmarelis, MD, highlights findings from a Lung-MAP nonmatched substudy presented at ASCO Annual Meeting. “The idea of sequential immunotherapy is something that we’re all grappling with in this era of multiple different immunotherapies approved in different lines,” Marmarelis, assistant professor of medicine at University of Pennsylvania, said. Reference: Reckamp KL, et al. Overall survival from a phase II randomized study of ramucirumab plus pembrolizumab versus standard of care for advanced non-small cell lung cancer previously treated with immunotherapy: Lung-MAP nonmatched substudy S1800A. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago. Read more about

Trizell Frequently Asked Questions (FAQ)

  • Where is Trizell's headquarters?

    Trizell's headquarters is located at Sanderum House, Chinnor.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.